The prognostic value of health-related quality of life for early molecular response in patients with chronic myeloid leukemia: analysis of the GIMEMA-SUSTRENIM trial [0.03%]
健康相关生活质量对慢性髓性白血病患者早期分子反应的预测价值：GIMEMA-SUSTRENIM试验分析
Fabio Efficace,Laura Cannella,Isabella Capodanno et al.
Fabio Efficace et al.
We aimed to explore the prognostic value of patient-reported health-related quality of life (HRQoL) data for the achievement of early molecular response (EMR) at 3 months in patients with chronic phase chronic myeloid leukemia (CP-CML). We ...
Therapeutic potential of TRIM family proteins in gastric cancer: from signaling pathway regulation to precision targeting strategies [0.03%]
TRIM家族蛋白在胃癌治疗中的潜力：从信号通路调控到精准靶向策略
Caiqing Zhao,Jialing Qi,Zhenze Zhang et al.
Caiqing Zhao et al.
Gastric cancer (GC) is a globally prevalent malignant tumor, causing approximately 770,000 deaths in 2020, ranking fourth among all cancers. The tripartite motif (TRIM) protein family is involved in various cellular regulations and has beco...
Seq-ing answers: exploring meningioma biology utilizing bulk RNA-seq-based reference landscapes [0.03%]
基于bulk RNA测序的参考谱系在脑膜瘤研究中的应用探索
Abigail G Parrish,Eric C Holland
Abigail G Parrish
Meningiomas are the most common primary brain tumors, accounting for 40% of all central nervous system neoplasms. While usually benign, these tumors can vary in aggressiveness. Traditional classification and grading systems, which primarily...
Case Report: Successful DSA-guided removal of a fractured PICC catheter from the pulmonary artery in a patient with lung cancer [0.03%]
个例报告：DSA引导下肺癌患者断裂的PICC导管肺动脉取出术顺利完成
Jun Lai,Xue Xiao,Chunyan Wen et al.
Jun Lai et al.
Background: Peripherally inserted central catheters (PICCs) are widely used for long-term intravenous therapy, especially in cancer patients. Although generally safe, PICC-related complications such as catheter fracture a...
CS Ratio is an immune-related prognostic biomarker for cervical cancer [0.03%]
CSRatio是一个免疫相关的宫颈癌预后生物标志物
Peiqin Shi,Wenwen Zhang,Qingqing Yao et al.
Peiqin Shi et al.
Background: The tumor microenvironment (TME) plays a crucial role in cancer progression but its complex structure significant variability among patients present considerable challenges for research. Recent studies have de...
Diagnostic pitfall in primary cervical gestational choriocarcinoma: a case report [0.03%]
原发性宫颈妊娠期绒癌的诊断陷阱：病例报告
Jiayu Shi,Ping Chen
Jiayu Shi
Choriocarcinoma belongs to a group of highly aggressive malignant gestational trophoblastic neoplasms. Choriocarcinoma is classified into two types based on the origin: a gestational type that arises following a normal or abnormal pregnancy...
Liquid clues: tracking early-stage breast cancer with ctDNA - a mini review [0.03%]
液体线索：通过循环肿瘤DNA追踪早期乳腺癌——综述文章
Saumya Easaw,Johann Hsu,Nury Steuerwald et al.
Saumya Easaw et al.
Circulating tumor DNA (ctDNA) is a testing modality that has several potential applications in the management of non-metastatic breast cancer. In this mini review, we discuss its role in early detection, treatment response assessment, and s...
Risk factors for recurrence and bleeding in colorectal cancer patients with cancer-associated venous thrombembolism [0.03%]
结直肠癌伴发癌栓患者的复发和出血危险因素分析
Zhikun Liang,Jieling Mao,Jingwen Xie et al.
Zhikun Liang et al.
Background: Colorectal cancer (CRC) patients with cancer-associated venous thromboembolism (VTE) face high risks of recurrence and anticoagulant-related bleeding. ...
Peripheral blood TCR repertoire improves early detection across multiple cancer types utilizing a cancer predictor [0.03%]
基于癌症预测模型的外周血TCR谱检测可早期发现多类癌症
Yinglei Tang,Xinyi Liao,Bo Liao et al.
Yinglei Tang et al.
Introduction: In the early asymptomatic stages of cancer, the immune system initiates a targeted response against tumor-associated antigens. During this phase, the immune system specifically identifies tumor antigens and ...
Sorafenib-to-regorafenib sequence-induced atherosclerotic cardiovascular disease: a novel case report [0.03%]
索拉非尼转瑞戈非尼序贯治疗诱导的动脉粥样硬化性心血管疾病：一例报告
Changli Xu,Xianghua Quan,Qie Guo et al.
Changli Xu et al.
This case report describes a 59-year-old male with HBV-associated hepatocellular carcinoma who developed progressive atherosclerotic cardiovascular disease (ASCVD) during sequential treatment with sorafenib and regorafenib. Initial sorafeni...